Stock Market News

Fractyl Health stock maintains Buy rating at Canaccord on positive trial data

Jun 24, 2025 - 13:06
 0
Fractyl Health stock maintains Buy rating at Canaccord on positive trial data
Read More

Tags:

Previous Article

Raymond James shuffles REITs: Upgrades Essex Property Trust, downgrades MAA

Next Article

Cidara stock price target raised to $68 on strong flu prevention data

Related Posts

US FDA advisers to weigh composition of COVID vaccines for 2025-2026

US FDA advisers to weigh composition of COVID vaccines ...

May 22, 2025  0

Peru expects $4.8 billion in mining investment this year, and slight increase in copper output

Peru expects $4.8 billion in mining investment this yea...

Jun 3, 2025  0

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.46%

Denmark stocks lower at close of trade; OMX Copenhagen ...

May 16, 2025  0